Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis

International Journal of COPD

Volumn 10, Issue , 2015, Pages 961-967

  Fernández Villar, Alberto ^a   López Campos, José Luis ^b,c   Represas, Cristina Represas ^a   Barrera, Lucía Marín ^c   Fernández, Virginia Leiro ^a   Ramírez, Cecilia López ^c   Casamor, Ricard ^d  

^a Instituto de Investigación Biomédica de Vigo   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d S A   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Diagnosis; Spirometry

Indexed keywords

BRONCHODILATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBESITY; OBSERVATIONAL STUDY; PHYSICIAN ATTITUDE; PREDICTIVE VALUE; SEX RATIO; SMOKING; SPIROMETRY; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECTS; HEALTH; LUNG; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SPAIN; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; RURAL HEALTH; SMOKING; SPAIN; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84929404146     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S79547     Document Type: Article

References (21)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
2. GesEPOC Task Force. [Clinical practice guideline for the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD) – Spanish guideline for COPD (GesEPOC)]. Arch Bronconeumol. 2012;48 Suppl 1:2–58. Spanish.
3. López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62.
4. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868.
5. Joo MJ, Au DH, Lee TA. Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care. Transl Res. 2009;154(3):103–110.
6. Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550–556.
7. Pellicer Císcar C, Soler Cataluña JJ, Andreu Rodríguez AL, Bueso Fabra J; on behalf of the EPOC group, Valencia Society of Respiratory Medicine. [Diagnosis of COPD in hospitalised patients]. Arch Bronconeumol. 2010;46(2):64–69. Spanish.
8. Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One. 2012;7(7):e42156.
9. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007;101(8):1753–1760.
10. Gershon AS, Hwee J, Croxford R, Aaron SD, To T. Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest. 2014;145(2):272–281.
11. Walters JA, Walters EH, Nelson M, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011;20(4):396–402.
12. Zwar NA, Marks GB, Hermiz O, et al. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust. 2011;195(4):168–171.
13. Collins BF, Ramenofsky D, Au DH, Ma J, Uman JE, Feemster LC. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest. 2014;146(6):1513–1520.
14. Collins BF, Feemster LC, Rinne S, Au DH. Factors predictive of airflow obstruction among veterans with presumed empiric diagnosis and treatment of COPD. Chest. 2015;147(2):369–376.
15. Yu WC, Fu SN, Tai EL, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013;8:389–395.
16. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008;134(1):38–45.
17. García-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e105220.
18. Joo MJ, Lee TA, Au DH, Fitzgibbon ML, Weiss KB. Medication use patterns associated with spirometry in diagnosing COPD. COPD. 2008;5(6):360–368.
19. Salinas GD, Williamson JC, Kalhan R, et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis. 2011;6:171–179.
20. Fernández-Villar A, Torres Durán M, Mosteiro Añón M, et al. Utilización de la espirometría en los Centros de Atención Primaria de Galicia [Use of spirometry in primary care centers in Galicia]. Pneuma. 2005;1:80–84. Spanish.
21. Díaz-Grávalos GJ, Palmeiro-Fernández G, Valiño-López MD, et al. [The adequacy of the diagnostic in chronic obstructive pulmonary disease]. Rev Calid Asist. 2012;27(6):305–310. Spanish.